Table 1

	Fixed oocytes after IVM n	Viewed by confocal N	MI n (%)	TI n (%)	PA n (%)	MII
Table 2. Stages of nuclear maturation, and percentages of normal MII oocytes matured in vitro in medium without follicular fluid (No-FF), with addition of 1% FF from infertile patients without endometriosis (FFC), with early endometriosis (FFEI/II), with advanced endometriosis without (FFEIII/IV) or with endometrioma (FFEndometrioma), supplemented with 0.6 mg/mL L-carnitine and 1 nM omega-3 (LC+n3) visualized by confocal microscopy.
	Fixed oocytes after IVM n	Viewed by confocal N	MI n (%)	TI n (%)	PA n (%)	Total MII n (%)	Analyzable n (%)	Normal n (%)
No-FF	167	149	9(6.0%)^a	2 (1.3%)	1 (0.7%)	137 (91.9%)^a	94 (68.6%)	82 (87.2%)^a
FFC	163	148	9 (6.1%)^a	5 (3.4%)	2 (1.4%)	132 (89.2%)^ab	78 (59.1%)	68 (87.2%)^a
FFC+LC+n3	179	163	19 (11.7%)^ab	3 (1.8%)	3 (1.8%)	138 (89.2%)^ab	80 (58.0%)	66 (82.5%)^ab
FFEI/II	178	158	20 (12.7%)^ab	1 (0.6%)	2 (1.3%)	135 (85.4%)^ab	82 (60.7%)	51 (62.2%)^c
FFEI/II +LC+n3	186	163	16 (9.8%)^ab	4 (2.5%)	4 (2.5%)	139 (85.3%)^ab	84 (60.4%)	71 (84.5%)^ad
FFEIII/IV	185	166	28 (16.9%)^bc	2 (1.2%)	2 (1.2%)	134 (80.7%)^b	84 (62.7%)	59 (70.2%)^bc
FFEIII/IV +LC+n3	163	142	11 (7.7%)^a	1 (0.7%)	1 (0.7%)	129 (90.8%)^a	82 (63.6%)	69 (84.1%)^ad
FFEndometrioma	163	150	37 (24.7%)^c	7 (4.7%)	2 (1.3%)	104 (69.3%)^c	66 (63.5%)	48 (72.7%)^bcd
FFEndometrioma +LC+n3	177	162	18 (11.1%)^ab	0 (0%)	0 (0%) 4 (2.5%)	140 (86.4%)^ab	85 (60.7%)	64 (75.3%)^abc

Note: IVM: in vitro maturation; MI=metaphase I; TI=telophase I; MII=metaphase II; PA=parthenogenetic activation. Analyzable: oocytes with spindles fixed in lateral or sagittal view. Data are results of 8 replicates using follicular fluid from control patients, with mild endometriosis, with severe endometriosis without endometrioma and with endometrioma. Different letters in the same column indicate statistical difference, p <0.05, using chi-square test.